<DOC>
	<DOCNO>NCT00551148</DOCNO>
	<brief_summary>The purpose study explore effective dose range PD0200390 treatment patient insomnia .</brief_summary>
	<brief_title>A Dose-ranging , Multicenter Polysomnography Trial PD 0200390 Adults With Primary Insomnia</brief_title>
	<detailed_description />
	<mesh_term>Sleep Initiation Maintenance Disorders</mesh_term>
	<criteria>3 month history Primary Insomnia ( DSMIV criterion ) Self report sleep criterion least 3 night per week past month ; sWASO ( subjective wake sleep onset ) equal great 60 min sLSO ( subjective latency sleep onset ) equal great 45 minute TST le equal 6.5 hr Maintain normal daytimeawake , nighttimesleep schedule PSG sleep criterion mean WASO equal great 60 min calculate 2 PSG screen night TST 3 7 hr 2 PSG screen night Mean LPS ( latency persistent sleep ) equal great 20 min calculate 2 PSG screen night Comorbid psychiatric disease disorder History presence breathingrelated disorder Multivariable Apnea risk index ( MAP ) equal great 0.5 screen History presence medical neurological condition interfere sleep Current use know psychotropic effect medication Excessive caffeine use Use alcohol sleep aid 2 standard drinks/day</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>July 2012</verification_date>
</DOC>